The store will not work correctly when cookies are disabled.
4-fluorobenzothioamide
ID: ALA5201008
Cas Number: 22179-72-2
PubChem CID: 737223
Product Number: F168715, Order Now?
Max Phase: Preclinical
Molecular Formula: C7H6FNS
Molecular Weight: 155.20
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=S)c1ccc(F)cc1
Standard InChI: InChI=1S/C7H6FNS/c8-6-3-1-5(2-4-6)7(9)10/h1-4H,(H2,9,10)
Standard InChI Key: VQFOHZWOKJQOGO-UHFFFAOYSA-N
Molfile:
RDKit 2D
10 10 0 0 0 0 0 0 0 0999 V2000
-1.0705 0.0014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3559 0.4137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3558 0.0018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3558 -0.8233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3541 -1.2351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0705 -0.8270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7852 -1.2396 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.0705 0.4144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0705 1.2396 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.7852 0.0018 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
6 7 1 0
3 8 1 0
8 9 2 0
8 10 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 155.20 | Molecular Weight (Monoisotopic): 155.0205 | AlogP: 1.46 | #Rotatable Bonds: 1 |
Polar Surface Area: 26.02 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 1 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.39 | CX Basic pKa: ┄ | CX LogP: 1.86 | CX LogD: 1.86 |
Aromatic Rings: 1 | Heavy Atoms: 10 | QED Weighted: 0.62 | Np Likeness Score: -1.72 |
References
1. Shishodia S, Nuñez R, Strohmier BP, Bursch KL, Goetz CJ, Olp MD, Jensen DR, Fenske TG, Ordonez-Rubiano SC, Blau ME, Roach MK, Peterson FC, Volkman BF, Dykhuizen EC, Smith BC.. (2022) Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment Screening., 65 (20.0): [PMID:36227159] [10.1021/acs.jmedchem.2c00864] |